Junwen Zhou
BSc, MSc, PhD
Senior Researcher
Junwen Zhou joined the Health Economics Research Centre (HERC) in October 2020 as Senior Researcher. His work focusses on economic analysis and modelling of chronic diseases using individual participant data from large randomised controlled trials and observational data with focus on cardiovascular disease prevention.
Junwen is experienced in health economic evaluation methods and applications. Prior to his current position, he worked as Modelling Lead in Global Health Economic and Value Assessment (HEVA) in Sanofi, France. Before that, he worked as Research Analyst, then Senior Analyst in Health Economic and Outcome Research (HEOR) in Creativ-Ceutical, France. He also has clinical experience, worked as Clinical Pharmacist Intern in Peking University Third Hospital, China.
Junwen received his PhD in Clinical Research and Public Health from Aix-Marseille University, France, with thesis focusing on economic modelling with discrete event simulation (DES) in schizophrenia. He received his MSc in Clinical Pharmacy from Peking University, China, with thesis focusing on evidence synthesis with network meta-analysis (NMA) in osteoporosis. He received his BSc in Pharmacy with dual degree in Economics from Peking University, China.
Key publications
-
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial.
Zhou J. et al, (2024), Pharmacoeconomics, 42, 261 - 273
-
Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion.
Ye Z. et al, (2023), CMAJ Open, 11, E443 - E450
-
P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data
Wu R. et al, (2022), Value in Health, 25, S16 - S16
-
Effects of Empagliflozin on Health Care Use and Quality of Life in CKD in the United Kingdom: Results from EMPA-KIDNEY
Zhou J. and Mihaylova BN., (2024), JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35
-
P55 Excess Annual Hospital Costs Due to Cardiovascular Events in a Contemporary UK Population to Inform Health Technology Assessments
Zhou J. et al, (2022), Value in Health, 25, S12 - S12
Recent publications
-
Effects of statin treatment on primary and hospital care use: a microsimulation model
Zhou J. et al, (2025)
-
Health and economic burden of chikungunya infection and potential benefits of vaccination in 32 countries: a vaccine impact modelling study
Zhou J. et al, (2025)
-
Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.
Zhou J. et al, (2025), Br J Psychiatry, 227, 545 - 552
-
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Zhou J. et al, (2025), EClinicalMedicine
-
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.
Yi Z. et al, (2024), BMC Public Health, 24